Agenus (NASDAQ:AGEN) Receives New Coverage from Analysts at StockNews.com
StockNews.com began coverage on shares of Agenus (NASDAQ:AGEN – Free Report) in a report released on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock. Other analysts have also issued research reports about the company. Robert W. Baird assumed coverage on Agenus in a report on Monday, June 5th. They set […]